Stock recommendations for 8 January from MarketSmith India
Why it’s recommended: Strong digital engineering and cloud-led revenue mix, consistent earnings growth with healthy margins, rising deal wins, and an improving order pipeline, strong client diversification across industries and geographies, and a healthy balance sheet with low debt levels.Key metrics: P/E: 64.91 | 52-week high: ₹6,599 | Volume: ₹409.23 croreTechnical analysis: Cup-with-handle breakoutRisk factors: Dependence on global IT spending cycles, pricing pressure from large IT peers and niche players, client concentration risk in key accounts, talent attrition and wage inflation impacting margins, and currency volatility affecting overseas revenues.Buy: ₹6,420-6,480Target price: ₹7,100 in two to three monthsStop loss: ₹6,100Why it’s recommended: Strong presence in chronic therapy segments, consistent earnings and cash flow generation, improving India formulations growth, a healthy product pipeline with regular launches, and a stable balance sheet with manageable debt.Key metrics: P/E: 65.98 | 52-week high: ₹4,104.80 | Volume: ₹361.85 croreTechnical analysis: Flat base breakoutRisk factors: Pricing pressure in the U.S. generics market, regulatory risks from the US FDA inspections, dependence on key molecules and markets, rising input and compliance costs, and currency volatility impacting margins.Buy at: ₹4,070-4,100Target price: ₹4,600 in two to three monthsStop loss: ₹3,820Indian equities ended marginally lower on Tuesday after a volatile session, with Nifty 50 slipping 0.14% to close at 26,140.75.
On the other hand, the Sensex also finished mildly in the red as investors booked profits at higher levels. The benchmark traded in a wide intraday range of 26,124-26,274, reflecting a tug of war between selective
. Read on livemint.com